Sun Pharma files new drug application with USFDA for investigational medicine to treat alopecia

The new drug application filing for deuruxolitinib with the USFDA is based on two pivotal Phase III trials, which included over 1,200 patients, across more than 135 clinical trial sites, the company said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fzNcvI9
via IFTTT